Disclosure Of First-Time Adoption [Text Block]

HEMOGENYX PHARMACEUTICALS PLC - Filing #5969073

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
29,423,915 GBP
21,388,546 GBP
35,045 GBP
44,020 GBP
435,955 GBP
1,508,572 GBP
6,157,894 GBP
13,983,115 GBP
853,494 GBP
2,781,006 GBP
23,804,734 GBP
1,164,637 GBP
37,723 GBP
19,938,556 GBP
11,755,660 GBP
- GBP
77,496 GBP
6,157,894 GBP
3,243,520 GBP
921,801 GBP
31,908 GBP
16,808,647 GBP
17,114,056 GBP
9,797,493 GBP
6,157,894 GBP
- GBP
980,563 GBP
Comprehensive income
- GBP
- GBP
- GBP
- GBP
5,983,937 GBP
- GBP
358,459 GBP
- GBP
5,793,426 GBP
- GBP
- GBP
- GBP
- GBP
903,067 GBP
- GBP
- GBP
Profit (loss)
- GBP
- GBP
- GBP
5,619,181 GBP
6,297 GBP
5,625,478 GBP
- GBP
- GBP
- GBP
6,696,493 GBP
- GBP
5,815 GBP
6,690,678 GBP
- GBP
- GBP
- GBP
- GBP
- GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.